Catalyst Wire Dossier Catalyst Wire Dossier

Ozurdex (dexamethasone intravitreal implant)

dexamethasone · AbbVie
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Ozurdex (dexamethasone intravitreal implant), covering 2014-06-18 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Dexamethasone Implant for Retinal Detachment in Uveal Melanoma [Phase 1]

See pricing